Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2020

01-12-2020 | Micafungin | Case report

Micafungin

Various toxicities: 7 case reports

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Mehta PA, et al. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: A pharmacokinetic study. Biology of Blood and Marrow Transplantation 16: 1458-1462, No. 10, Oct 2010. Available from: URL: http://​doi.​org/​10.​1016/​j.​bbmt.​2010.​05.​002
Metadata
Title
Micafungin
Various toxicities: 7 case reports
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-87702-z

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Heparin/warfarin

Case report

Pertuzumab/trastuzumab

Case report

Octreotide

Case report

Lenalidomide

Case report

Morphine

Case report

Adalimumab